Tag: illegal drug marketing

SCOTUS Declines Risperdal Appeal, J&J to Pay $124 M

10
On Monday, the US Supreme Court declined to hear Johnson and Johnsonā€™s final appeal, forcing the company to pay $124 million for the deceptive marketing of the antipsychotic Risperdal. In 2011, South Carolina ordered the company to pay $327 million for pursuing ā€œprofits-at-all-costsā€ in its efforts to persuade doctors to prescribe their drug, but the fine was lowered to $136 million last year. The company had hoped to argue that the remaining penalties constituted an ā€œexcessive fineā€ and was supported by PhRMA, the Washington Legal Foundation, the Cato Institute and the Chamber of Commerce.